✦ LIBER ✦

Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer

✍ Scribed by Silvia Dellapasqua; Manuelita Mazza; Debora Rosa; Raffaella Ghisini; Eloise Scarano; Rosalba Torrisi; Patrick Maisonneuve; Giuseppe Viale; Enrico Cassano; Paolo Veronesi; Alberto Luini; Aron Goldhirsch; Marco Colleoni

Book ID: 113507338
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 134 KB
Volume: 20
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2011.02.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated liposomal doxorubicin in combi

Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study

✍ Alexandros Ardavanis; Dimitris Mavroudis; Kostas Kalbakis; Nikolaos Malamos; Kos 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 292 KB

Phase II Trial of Combination of Pegylat

Phase II Trial of Combination of Pegylated Liposomal Doxorubicin, Cisplatin, and Infusional 5-Fluorouracil (CCF) Plus Trastuzumab as Preoperative Treatment for Locally Advanced and Inflammatory Breast Cancer

✍ Rosalba Torrisi; Anna Cardillo; Giuseppe Cancello; Silvia Dellapasqua; Alessandr 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 746 KB

Pegylated liposomal doxorubicin as first

Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: Novel treatment predictive factors identified

✍ H. Green; O. Stål; K. Bachmeier; L.M. Bäcklund; L. Carlsson; J. Hansen; M. Lager 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 885 KB

Non-pegylated liposomal doxorubicin comb

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

✍ S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB

Phase II study of pegylated liposomal do

Phase II study of pegylated liposomal doxorubicin HCI (caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer

✍ Leighl, Natasha B.; Goss, Glenwood D.; Lopez, Pedro; Burkes, Ronald L.; Dancey, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Phase II study of pegylated liposomal do

Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer

✍ Leighl, Natasha B.; Goss, G.D.; Lopez, P.G.; Burkes, R.L.; Dancey, J.E.; Rahim, 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 168 KB